Article

<i>In vitro</i> nonalcoholic fatty liver disease model with cyclo-olefin-polymer-based microphysiological systems

2020-12-29

Abstract excerpt

Nonalcoholic fatty liver disease (NAFLD) is one of the common chronic liver conditions, whose treatment involves curing patients without liver transplantation. Understanding the mechanism of NAFLD initiation and progression would enable development of new diagnostic tools and drugs; however, until now, the underlying mechanisms of this condition remain largely unknown owing to the lack of experimental settings tha...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 9f2a0380-af94-58bd-9b82-0c0896310859
DOI: 10.1101/2020.12.28.424535

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

<i>In vitro</i> nonalcoholic fatty liver disease model with cyclo-olefin-polymer-based microphysiological systemsDOI 10.1101/2020.12.28.424535Read

Integrated gut–liver-on-a-chip platform as an <i>in vitro</i> human model of non-alcoholic fatty liver diseaseSemantic proximity Read

Cyclo olefin polymer-based solvent-free mass-productive microphysiological systemsSemantic proximity Read

Micropatterned Primary Hepatocyte Co-Culture (HEPATOPAC) for Fatty Liver Disease Modeling and Drug ScreeningSemantic proximity Read

A 3D human liver model of nonalcoholic steatohepatitisSemantic proximity Read

Exploring the Impacts of Polyethylene Microplastics on Rat LiverSemantic proximity Read

Toxicity of microplastics and plastic additive co-exposure in liver Disse organoids from healthy donors and patient-derived induced pluripotent stem cellsSemantic proximity Read

A 3D primary human cell-based in vitro model of non-alcoholic steatohepatitis for efficacy testing of clinical drug candidatesSemantic proximity Read

A microvascularized <i>in vitro</i> liver model for disease modeling and drug discoverySemantic proximity Read

Novel 3D Approach to Model Non-Alcoholic Fatty Liver Disease using human Pluripotent Stem CellsSemantic proximity Read

A novel bioreactor technology for modelling fibrosis in human and rodent precision-cut liver slicesSemantic proximity Read

Precision-Cut Liver Slices as an <i>ex vivo</i> model to evaluate antifibrotic therapies for liver fibrosis and cirrhosisSemantic proximity Read

Best Practices and Progress in Precision-Cut Liver Slice CulturesSemantic proximity Read